Hennion & Walsh Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.35M | Sell |
319,225
-50,672
| -14% | -$849K | 0.22% | 101 |
|
|
2025
Q1 | $5.69M | Sell |
369,897
-1,686
| -0.5% | -$25.9K | 0.25% | 83 |
|
|
2024
Q4 | $8.19M | Buy |
371,583
+61,467
| +20% | +$1.35M | 0.37% | 48 |
|
|
2024
Q3 | $5.59M | Buy |
310,116
+20,837
| +7% | +$375K | 0.26% | 84 |
|
|
2024
Q2 | $4.7M | Buy |
289,279
+83,117
| +40% | +$1.35M | 0.24% | 93 |
|
|
2024
Q1 | $2.91M | Buy |
206,162
+47,954
| +30% | +$677K | 0.16% | 178 |
|
|
2023
Q4 | $1.65M | Buy |
158,208
+70,603
| +81% | +$737K | 0.09% | 282 |
|
|
2023
Q3 | $894K | Buy |
87,605
+40,424
| +86% | +$412K | 0.06% | 384 |
|
|
2023
Q2 | $355K | Buy |
+47,181
| New | +$355K | 0.02% | 609 |
|
|
2021
Q4 | – | Sell |
-125,913
| Closed | -$1.23M | – | 785 |
|
|
2021
Q3 | $1.23M | Sell |
125,913
-5,435
| -4% | -$52.9K | 0.06% | 312 |
|
|
2021
Q2 | $1.3M | Buy |
131,348
+303
| +0.2% | +$3K | 0.07% | 312 |
|
|
2021
Q1 | $1.51M | Buy |
+131,045
| New | +$1.51M | 0.09% | 277 |
|